• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Oncology Information Systems Market

    ID: MRFR/Pharma/48650-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Oncology Information Systems Market Research Report By Product Type (Software, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology) and By End User (Hospitals & Oncology Clinics, Government Institutes, Research Centers)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Oncology Information Systems Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    UK Oncology Information Systems Market Summary

    The United Kingdom UK Oncology Information Systems market is poised for substantial growth, projected to reach 1029 USD Million by 2035.

    Key Market Trends & Highlights

    UK Oncology Information Systems Key Trends and Highlights

    • The market valuation is estimated at 440.2 USD Million in 2024.
    • By 2035, the market is expected to grow to 1029 USD Million, indicating a robust expansion.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is projected at 8.02%.
    • Growing adoption of advanced oncology information systems due to increasing cancer prevalence is a major market driver.

    Market Size & Forecast

    2024 Market Size 440.2 (USD Million)
    2035 Market Size 1029 (USD Million)
    CAGR (2025-2035) 8.02%

    Major Players

    Siemens Healthineers, GenesisCare, Oracle Corporation, Elekta, RaySearch Laboratories, Cerner Corporation, Philips Healthcare, AccuTarget, Varian Medical Systems, McKesson Corporation, IBM Watson Health, Mirada Medical, GE Healthcare, OncoOne, CIVCO Medical Solutions

    UK Oncology Information Systems Market Trends

    The UK Oncology Information Systems Market is experiencing significant trends driven by regulatory support and technological advancements. With the National Health Service (NHS) focusing on digital transformation to improve patient care, there is an increasing emphasis on integrating advanced oncology information systems within healthcare facilities. 

    This aligns with the NHS Long Term Plan, which aims to enhance cancer services by utilizing data more effectively for patient management and treatment. Key market drivers include the rising incidence of cancer and the need for efficient management systems to handle patient data and treatment protocols.The push for personalized medicine requires robust data analytics capabilities within oncology information systems, enabling healthcare professionals to tailor treatments based on individual patient profiles. 

    The continuous evolution of telemedicine and remote monitoring due to the recent focus on patient-centric care offers further chances for system integration and market expansion.Trends in recent times indicate a heightened collaboration between technology firms and healthcare organizations, promoting a streamlined development of oncology systems. 

    Additionally, there is a growing engagement from oncology specialists in the refining and customization of these systems, ensuring they meet the clinical requirements specific to the UK. As healthcare in the UK continues to adapt to the demands of modern medicine, the oncology information systems market is poised for growth and transformation, driven by these emerging trends and opportunities.

    UK Oncology Information Systems Market Drivers

    Market Segment Insights

    UK Oncology Information Systems Market Segment Insights

    UK Oncology Information Systems Market Segment Insights

    Oncology Information Systems Market Product Type Insights

    Oncology Information Systems Market Product Type Insights

    The UK Oncology Information Systems Market exhibits significant growth potential in its Product Type segment, which broadly encompasses Software and Professional Services. This segment plays a critical role in the enhancement of oncology care and management within the UK, which is essential in addressing the rising cancer cases necessitating efficient treatment options and management systems. The demand for advanced software solutions, such as electronic health records and treatment planning systems, has surged in recent years as healthcare providers seek to streamline operations and enhance patient outcomes.

    Moreover, the uptake of professional services, which includes consulting, training, and support, has become vital for the successful implementation and ongoing optimization of oncology information systems. These services ensure that healthcare providers can maximize the utility of their software investments while maintaining compliance with evolving healthcare regulations and standards in the UK.

    The significance of Software within the Oncology Information Systems Market cannot be understated, as it supports the management of large datasets, patient information, and treatment protocols which are crucial for clinical decision-making. Software innovations are increasingly being leveraged to integrate artificial intelligence and big data analytics, offering insights that were once unattainable and thus driving improved patient care and resource allocation. Similarly, Professional Services are essential in addressing the complexities associated with the deployment of these systems, providing the required expertise to navigate the challenges of interoperability, data security, and user training.

    Furthermore, as the healthcare landscape in the UK shifts towards enhanced digitization and value-based care models, there is a growing recognition of the need for robust oncology information systems that can adapt to changing healthcare policies and provide comprehensive analytics that facilitate evidence-based decision-making. This trend toward integrated and patient-centered care reinforces the importance of both Software and Professional Services in supporting healthcare providers to deliver high-quality care while optimizing operational efficiency.

    The UK's commitment to advancing its oncology services through the integration of cutting-edge technology and skilled professional support is expected to drive continued growth in this segment of the market, reflecting the broader trend towards digital transformation in the healthcare industry. Overall, the Product Type segment of the UK Oncology Information Systems Market demonstrates a strong trajectory toward innovation, driven by the pressing need for improved cancer care solutions that leverage both advanced software solutions and dedicated professional services for optimal implementation and user adoption.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Oncology Information Systems Market Application Insights

    Oncology Information Systems Market Application Insights

    The UK Oncology Information Systems Market focused on the Application segment comprises vital areas such as Medical Oncology, Radiation Oncology, and Surgical Oncology, each playing a crucial role in patient care and management. Medical Oncology is significant as it encompasses the use of anti-cancer medications and personalized therapies, reflecting the growing trend towards custom treatment plans that cater to individual patient needs.

    Radiation Oncology, on the other hand, dominates in offering advanced technologies for targeted radiation treatments, enhancing treatment efficacy while minimizing damage to surrounding tissues.Surgical Oncology remains a cornerstone of cancer treatment, emphasizing the importance of precise surgical interventions to ensure the successful removal of tumors. 

    As the UK government continues to invest in health technologies and prioritize cancer care, these Applications are expected to be more integrated within healthcare systems, leading to improved patient outcomes and streamlined workflows. The increasing demand for these services is driven by rising cancer incidence rates and advancements in technology, providing opportunities for market growth and innovation within the Oncology Information Systems landscape.

    Oncology Information Systems Market End User Insights

    Oncology Information Systems Market End User Insights

    The End User segment of the UK Oncology Information Systems Market comprises essential contributors, including Hospitals and Oncology Clinics, Government Institutes, and Research Centers. Hospitals and Oncology Clinics are pivotal in the delivery of cancer care, utilizing advanced information systems to streamline patient management, treatment planning, and data integration to enhance clinical outcomes. Government Institutes play a critical role in healthcare policy implementation and funding for oncology research, ensuring access to innovative treatment solutions for the population.

    Research Centers are integral for facilitating groundbreaking advancements in cancer therapies and treatment modalities, supported by sophisticated information systems that aid in data collection and analysis. Together, these entities drive the UK Oncology Information Systems Market, addressing the growing demand for efficient oncology workflows and personalized patient care. Ongoing investments in technology and digitalization further bolster this segment, as healthcare providers prioritize integrated data systems to optimize patient experiences and outcomes, shaping the future landscape of oncology care in the UK.

    Get more detailed insights about UK Oncology Information Systems Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The competitive landscape of the UK Oncology Information Systems Market is characterized by rapid advancements in technology and a growing demand for efficient patient management solutions. The market is witnessing a shift towards integrated oncology information systems that not only streamline clinical workflow but also enhance patient care through better data management and analytics. Key players in the market are focusing on developing innovative solutions that incorporate artificial intelligence and machine learning to improve diagnostic accuracy and treatment planning.

    The competitive dynamics are influenced by the increasing prevalence of cancer in the UK, coupled with the need for healthcare providers to adopt advanced information systems to optimize their operations and meet regulatory standards. 

    As a result, companies are investing heavily in research and development, forging strategic partnerships, and exploring mergers and acquisitions to expand their product offerings and strengthen their market position.Siemens Healthineers holds a prominent position in the UK Oncology Information Systems Market, leveraging its deep expertise in imaging and medical technology to offer comprehensive solutions that support oncologists in patient diagnosis and treatment. The company’s strengths lie in its robust portfolio of imaging equipment coupled with advanced oncology information systems that enable seamless integration of clinical data.

    Siemens Healthineers successfully combines innovative technology with clinical insights, facilitating improved patient outcomes through enhanced treatment planning. Its established presence in the UK healthcare sector, bolstered by a reputation for high-quality products and reliable customer support, enables the company to maintain a competitive edge. 

    The strong focus on R&D allows Siemens Healthineers to consistently evolve its solutions, catering to the dynamic demands of oncology healthcare providers and ensuring that they remain at the forefront of technological advancements in the market.GenesisCare is a notable player in the UK Oncology Information Systems Market, recognized for its commitment to providing high-quality cancer care through advanced treatment solutions and integrated services. The company has a strong presence in the UK, offering key products such as advanced radiation therapy systems and comprehensive oncology information management systems designed to optimize patient experience and enhance treatment efficacy. 

    GenesisCare's strengths lie in its collaborative approach, working closely with healthcare professionals to tailor solutions that meet specific clinical needs. The company has also made strategic investments and acquisitions to expand its capabilities and geographic reach, significantly enhancing its service offerings and market position within the UK oncology landscape. By focusing on cutting-edge technology and evidence-based treatment protocols, GenesisCare continues to strengthen its role in the oncology information systems market, aiming to improve the overall patient journey while maintaining a high standard of care.

    Key Companies in the UK Oncology Information Systems Market market include

    Industry Developments

    The UK Oncology Information Systems Market has seen several important developments recently. Siemens Healthineers announced advancements in imaging technology designed to enhance cancer diagnoses as of August 2023, while Elekta launched new software solutions to improve precision treatment planning in July 2023. In the realm of mergers and acquisitions, Oracle Corporation completed its acquisition of Cerner Corporation in June 2023, reinforcing its commitment to health data integration, which is crucial for oncology applications. Additionally, Varian Medical Systems introduced an innovative oncology clinical decision support platform in September 2023, further enriching the market landscape. 

    The market valuation for oncology information systems in the UK is expected to grow significantly, with analysts forecasting a robust increase driven by technological advancements and a greater emphasis on personalized medicine. Over the past few years, RaySearch Laboratories has gained traction by entering strategic partnerships in UK healthcare, particularly in collaboration with NHS trusts to streamline treatment processes. There is a growing emphasis on data-driven solutions within oncology, with UK stakeholders increasingly seeking integrated systems that facilitate collaboration among various healthcare entities to improve patient outcomes.

    Market Segmentation

    Outlook

    • Hospitals & Oncology Clinics
    • Government Institutes
    • Research Centers

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 440.25(USD Million)
    MARKET SIZE 2024 483.0(USD Million)
    MARKET SIZE 2035 1029.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.118% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Siemens Healthineers, GenesisCare, Oracle Corporation, Elekta, RaySearch Laboratories, Cerner Corporation, Philips Healthcare, AccuTarget, Varian Medical Systems, McKesson Corporation, IBM Watson Health, Mirada Medical, GE Healthcare, OncoOne, CIVCO Medical Solutions
    SEGMENTS COVERED Product Type, Application, End User
    KEY MARKET OPPORTUNITIES Telehealth integration for oncology care, Real-time data analytics adoption, AI-driven treatment personalization, Cloud-based system implementations, Increased focus on patient engagement tools
    KEY MARKET DYNAMICS increasing cancer prevalence, technological advancements, regulatory compliance, growing demand for personalized treatment, integration with electronic health records
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the UK Oncology Information Systems Market in 2024?

    The UK Oncology Information Systems Market is expected to be valued at 483.0 million USD in 2024.

    What is the projected market size by 2035 for the UK Oncology Information Systems Market?

    By 2035, the market is projected to be valued at 1029.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the UK Oncology Information Systems Market from 2025 to 2035?

    The expected CAGR for the UK Oncology Information Systems Market from 2025 to 2035 is 7.118%.

    What product type dominates the UK Oncology Information Systems Market?

    In the market, software is anticipated to dominate with a value of 290.0 million USD in 2024.

    How much is the professional services segment expected to be worth in 2024 within the UK Oncology Information Systems Market?

    The professional services segment is anticipated to be valued at 193.0 million USD in 2024.

    Who are the key competitors in the UK Oncology Information Systems Market?

    Major players in the market include Siemens Healthineers, GenesisCare, Oracle Corporation, and Cerner Corporation.

    What is the value of the software segment in the UK Oncology Information Systems Market projected for 2035?

    The software segment is projected to reach a value of 610.0 million USD by 2035.

    What growth opportunities exist in the UK Oncology Information Systems Market?

    The market offers growth opportunities through advancements in technology and increasing demand for integrated solutions.

    What market size is the professional services segment expected to reach by 2035?

    By 2035, the professional services segment is expected to grow to a value of 419.0 million USD.

    How does the UK Oncology Information Systems Market align with global trends?

    The market aligns with global trends focusing on personalized medicine and data-driven diagnostics to enhance treatment outcomes.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Oncology Information Systems Market, BY Product Type (USD Million)
    45. Software
    46. Professional Services
    47. UK Oncology Information Systems Market, BY Application (USD Million)
    48. Medical Oncology
    49. Radiation Oncology
    50. Surgical Oncology
    51. UK Oncology Information Systems Market, BY End User (USD Million)
    52. Hospitals & Oncology Clinics
    53. Government Institutes
    54. Research Centers
    55. Competitive Landscape
    56. Overview
    57. Competitive Analysis
    58. Market share Analysis
    59. Major Growth Strategy in the Oncology Information Systems Market
    60. Competitive Benchmarking
    61. Leading Players in Terms of Number of Developments in the Oncology Information Systems Market
    62. Key developments and growth strategies
    63. New Product Launch/Service Deployment
    64. Merger & Acquisitions
    65. Joint Ventures
    66. Major Players Financial Matrix
    67. Sales and Operating Income
    68. Major Players R&D Expenditure. 2023
    69. Company Profiles
    70. Siemens Healthineers
    71. Financial Overview
    72. Products Offered
    73. Key Developments
    74. SWOT Analysis
    75. Key Strategies
    76. GenesisCare
    77. Financial Overview
    78. Products Offered
    79. Key Developments
    80. SWOT Analysis
    81. Key Strategies
    82. Oracle Corporation
    83. Financial Overview
    84. Products Offered
    85. Key Developments
    86. SWOT Analysis
    87. Key Strategies
    88. Elekta
    89. Financial Overview
    90. Products Offered
    91. Key Developments
    92. SWOT Analysis
    93. Key Strategies
    94. RaySearch Laboratories
    95. Financial Overview
    96. Products Offered
    97. Key Developments
    98. SWOT Analysis
    99. Key Strategies
    100. Cerner Corporation
    101. Financial Overview
    102. Products Offered
    103. Key Developments
    104. SWOT Analysis
    105. Key Strategies
    106. Philips Healthcare
    107. Financial Overview
    108. Products Offered
    109. Key Developments
    110. SWOT Analysis
    111. Key Strategies
    112. AccuTarget
    113. Financial Overview
    114. Products Offered
    115. Key Developments
    116. SWOT Analysis
    117. Key Strategies
    118. Varian Medical Systems
    119. Financial Overview
    120. Products Offered
    121. Key Developments
    122. SWOT Analysis
    123. Key Strategies
    124. McKesson Corporation
    125. Financial Overview
    126. Products Offered
    127. Key Developments
    128. SWOT Analysis
    129. Key Strategies
    130. IBM Watson Health
    131. Financial Overview
    132. Products Offered
    133. Key Developments
    134. SWOT Analysis
    135. Key Strategies
    136. Mirada Medical
    137. Financial Overview
    138. Products Offered
    139. Key Developments
    140. SWOT Analysis
    141. Key Strategies
    142. GE Healthcare
    143. Financial Overview
    144. Products Offered
    145. Key Developments
    146. SWOT Analysis
    147. Key Strategies
    148. OncoOne
    149. Financial Overview
    150. Products Offered
    151. Key Developments
    152. SWOT Analysis
    153. Key Strategies
    154. CIVCO Medical Solutions
    155. Financial Overview
    156. Products Offered
    157. Key Developments
    158. SWOT Analysis
    159. Key Strategies
    160. References
    161. Related Reports
    162. UK Oncology Information Systems Market SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD Billions)
    163. UK Oncology Information Systems Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    164. UK Oncology Information Systems Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    165. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    166. ACQUISITION/PARTNERSHIP
    167. MARKET SYNOPSIS
    168. UK ONCOLOGY INFORMATION SYSTEMS MARKET ANALYSIS BY PRODUCT TYPE
    169. UK ONCOLOGY INFORMATION SYSTEMS MARKET ANALYSIS BY APPLICATION
    170. UK ONCOLOGY INFORMATION SYSTEMS MARKET ANALYSIS BY END USER
    171. KEY BUYING CRITERIA OF ONCOLOGY INFORMATION SYSTEMS MARKET
    172. RESEARCH PROCESS OF MRFR
    173. DRO ANALYSIS OF ONCOLOGY INFORMATION SYSTEMS MARKET
    174. DRIVERS IMPACT ANALYSIS: ONCOLOGY INFORMATION SYSTEMS MARKET
    175. RESTRAINTS IMPACT ANALYSIS: ONCOLOGY INFORMATION SYSTEMS MARKET
    176. SUPPLY / VALUE CHAIN: ONCOLOGY INFORMATION SYSTEMS MARKET
    177. ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT TYPE, 2025 (% SHARE)
    178. ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
    179. ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2025 (% SHARE)
    180. ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    181. ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2025 (% SHARE)
    182. ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    183. BENCHMARKING OF MAJOR COMPETITORS

    UK Oncology Information Systems Market Segmentation

     

     

     

    • Oncology Information Systems Market By Product Type (USD Million, 2019-2035)

      • Software
      • Professional Services

     

    • Oncology Information Systems Market By Application (USD Million, 2019-2035)

      • Medical Oncology
      • Radiation Oncology
      • Surgical Oncology

     

    • Oncology Information Systems Market By End User (USD Million, 2019-2035)

      • Hospitals & Oncology Clinics
      • Government Institutes
      • Research Centers

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027